374Water Inc.

The company’s disclosed commercial activity is currently centered in the United States, with named projects and demonstrations in Florida (City of Orlando), Michigan (Detroit demonstration in partnership with the Defense Innovation Unit), and California (Orange County Sanitation District in Fountain Valley). It also maintains R&D and operational footprint including a North Carolina lab lease that commenced in October 2024 and has relocated manufacturing/operations to Florida. While it describes itself as a global company, the report excerpts primarily evidence U.S.-based deployments, which matters because permitting and customer procurement are often local/regional. Geographic concentration increases exposure to U.S. municipal budget cycles and U.S. federal contracting timelines, while multi-site demonstrations can accelerate referenceability across states.

Commercialization risk is central: the company notes limited operating history and no material revenues, and its ability to treat hazardous wastes on a commercially viable basis remains unproven, making adoption dependent on successful demonstrations and customer satisfaction. Execution risk is elevated because system deployments rely on third parties for components, manufacturing, and timely installation; supplier delays or quality issues can push out revenue recognition and damage customer relationships. Regulatory and permitting requirements can constrain where and how AirSCWO and WDS hubs operate, particularly for hazardous waste and PFAS/AFFF streams. Competitive risk is meaningful given larger, better-capitalized incumbents that can discount, bundle offerings, or provide project financing, while the company also faces going-concern and capital-raising risk that can limit its ability to scale manufacturing and service hubs.